Who Owns PHIO?

Phio Pharmaceuticals Corp. — Institutional Ownership & 13F Holdings

$1.22

+0.04 (+3.38%)

Market Cap

$13.1M

Shares Outstanding

11,617,250

Institutional Holders

11

Total Inst. Value

$129K

% of Float Held

1.0%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GEODE CAPITAL MANAGEMENT, LLC$53K41,586
2Cetera Investment Advisers$50K38,500
3XTX Topco Ltd$14K10,800
4MORGAN STANLEY$7K6,000
5Tower Research Capital LLC (TRC)$3K2,501
6SBI Securities Co., Ltd.$1K968
7ASSETMARK, INC$143110
8UBS Group AG$134103
9Activest Wealth Management$129
10BARCLAYS PLC$05

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
UBS Group AG-2K$134
Tower Research Capital LLC (TRC)-2K$3K
BARCLAYS PLC-198$0

Related Stocks

Frequently Asked Questions

How many institutional investors hold PHIO?

As of Q1 2025, 11 institutional investors report holding PHIO (Phio Pharmaceuticals Corp.) in their 13F filings.

What percentage of Phio Pharmaceuticals Corp. is owned by institutions?

Institutional investors hold approximately 1.0% of Phio Pharmaceuticals Corp.'s float as reported in SEC 13F filings.

Which hedge fund owns the most PHIO?

The largest institutional holder of PHIO is GEODE CAPITAL MANAGEMENT, LLC with $53K in shares.

Are institutions buying or selling PHIO?

This quarter, 4 institutions opened new positions in PHIO and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.